| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.35 | 7e-07 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |